宜宾切开式双眼皮手术(宜宾割双眼皮哪种比较自然) (今日更新中)

BEIJING/CHONGQING, Oct. 16 (Xinhua) -- A team of Chinese and American scientists have discovered the world's only evidence of co-existing human beings and dinosaur tracks in a remote county in southwest China's Chongqing Municipality, according to a paper published Saturday in the Geological Bulletin of China, a Chinese core academic journal.Qijiang County's Lianhua Baozhai, which means "Lotus Mountain Fortress" in Chinese, has a large number of dinosaur tracks as well as a well-preserved fortress and historical epigraph, forming a direct line of evidence that ancient Chinese people built a residence and lived there for a long time, said Xing Lida, one of three researchers with the project as well as a doctoral degree candidate with the Department of Biological Sciences of the University of Alberta in Canada.Chinese people could have lived here for more than 700 years, and the mud cracks, ripple marks and duck-billed dinosaur tracks were considered by them to be lotus leaf veins, water environment and lotus, respectively, which is why they named it the Lotus Mountain Fortress, Xing Lida told Xinhua."Research shows that dinosaur tracks impacted ancient Chinese place names and folklore, so place names and folklore can be major clues for us in tracing dinosaur tracks," Xing said.According to the paper, the Lotus Mountain Fortress dinosaur tracks, the largest track group of cretaceous dinosaurs in southwestern China, contains 350 to 400 footprints that had been preserved in many ways, including concave footprints, convex footprints and multilayered footprints.

MOSCOW, Oct. 3 (Xinhua) -- A Soyuz-2.1B rocket carried a Glonass-M navigation satellite into orbit early Monday after a two-day delay caused by high winds, a Russian Space Forces spokesman said."The launch of the booster rocket is as scheduled. The satellite Glonass-M was put into the orbit under control at 03:55 Moscow time (2355 GMT on Sunday)," said Colonel Alexei Zolotukhin.Zolotukhin told reporters that the rocket was launched at 0:15 Moscow time (2015 GMT, Sunday) from the Plesetsk Space Center in northern Russia.The Russian Space Forces said the launch was initially scheduled for Saturday but was postponed due to high winds.Glonass is the Russian equivalent of the U.S. Global Positioning System (GPS), which is designed for both military and civilian use. The system requires 24 operational and 2-3 reserve satellites in orbit to ensure global coverage.In December 2010, a malfunction of the booster resulted in a loss of three Glonass satellites.

BEIJING, Jan. 17 (Xinhuanet) -- India has reported the first case of "totally drug-resistant tuberculosis," a long-feared and virtually untreatable form of the killer lung disease.Similar highly resistant cases have been noted before. In 2003, two Italian women died and there were 15 cases reported from Iran in 2009. That same year, The Associated Press reported on a case of a Peruvian teenager who was infected at home but diagnosed while visiting Florida.Such kind of TB has mostly been limited to impoverished areas, and has not spread widely. But experts believe there could be many undocumented cases.No one expects the Indian TB strains to rapidly spread elsewhere.The airborne disease is mainly transmitted through close personal contact and isn't nearly as contagious as the flu. Indeed, most of the cases of this kind of TB were not from person-to-person infection but were mutations that occurred in poorly treated patients.The Indian hospital that saw the initial cases tested a dozen medicines and none of them worked. A TB expert at the U.S. Centers for Disease Control and Prevention said they do appear to be totally resistant to available drugs."It is concerning," said Dr. Kenneth Castro, director of the CDC's Division of Tuberculosis Elimination. "Anytime we see something like this, we better get on top of it before it becomes a more widespread problem."Ordinary TB is easily cured by taking antibiotics for six to nine months. However, if that treatment is interrupted or the dose is cut down, the stubborn bacteria battle back and mutate into a tougher strain that can no longer be killed by standard drugs. The disease becomes harder and more expensive to treat.Tuberculosis is an age-old scourge that lies dormant in an estimated one in three people. About 10 percent of those people eventually develop active TB, which kills roughly 2 million a year, according to WHO. Each victim infects an average of 10 to 15 others every year, typically through sneezing or coughing.If a TB case is found to be resistant to the two most powerful anti-TB drugs, the patient is classified as having multi-drug-resistant TB (MDR). An even worse classification of TB — one the WHO accepts — is extensively drug-resistant TB (XDR), a form of the disease that was first reported in 2006 and is virtually resistant to all drugs.About 20 percent of the world's multi-drug-resistant cases were found in India, which is home to a quarter of all types of tuberculosis cases worldwide.

BEIJING, Nov. 22 (Xinhuanet) -- Underweight patients may have more possibilities of mortality within 30 days of general and vascular surgery compared with mildly obese patients, according to a research published online in Archives of Surgery Tuesday.Researchers at the U.S. National Surgical Quality Improvement Program conducted the research for the years 2005 and 2006, and assessed the contribution of BMI (Body Mass Index) to 189,533 postsurgeries morbidity and mortality by obesity classes.They found that compared with the middle BMI quintile group, patients with BMI value below 23.1, had greater chances for death. For the highest BMI quintile group, higher mortality rate was also observed.However, the researchers also found that obesity may as well be associated with increased mortality for some individual types of surgeries."These individual types of procedures include procedures with which the general surgeon should have definite experience: colorectal resection, colostomy formation, cholecystectomy, hernia repair, mastectomy, and wound debridement," said George J. Stukenborg, PhD, of the University of Virginia inCharlottesvilleand his colleagues.Based on a 30 –day morbidity and mortality risk calculation, the sample patients were categorized into BMI quintile ranges. BMI value of less than 23.1 was considered as lowest, values from 26.3 to 29.6 considered as the middle quintile, and above 35.2 considered as the highest.Factors such as lack of enough data on nonfatal complications and hospital resources, or examining mortality over the 30-day baseline, may cause limitations and inaccuracy to the research and more studies on a wider range of patients in terms of BMI are needed to further confirm the current conclusion, researchers said.

WASHINGTON, Oct. 6 (Xinhua) -- The U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) announced Thursday a joint, large-scale, national study of tobacco users to monitor and assess the behavioral and health impacts of new government tobacco regulations.The initiative is the first large-scale NIH/FDA collaboration on tobacco regulatory research since the U.S. Congress granted FDA the authority to regulate tobacco products in an act in 2009. Scientists at NIH's National Institute on Drug Abuse and the FDA's Center for Tobacco Products will coordinate the effort."The launch of this study signals a major milestone in addressing one of the most significant public health burdens of the 21st century," said FDA Commissioner Margaret Hamburg in a statement. "The results will strengthen FDA's ability to fulfill our mission to make tobacco-related death and disease part of America's past and will further guide us in targeting the most effective actions to decrease the huge toll of tobacco use on our nation's health."Investigators will follow more than 40,000 users of tobacco- product and those at risk for tobacco use ages 12 and older. They will examine what makes people susceptible to tobacco use; evaluate use patterns and resulting health problems; study patterns of tobacco cessation and relapse in the era of tobacco regulation; evaluate the effects of regulatory changes on risk perceptions and other tobacco-related attitudes; and assess differences in attitudes, behaviors and key health outcomes in racial-ethnic, gender, and age subgroups."We are pleased to collaborate with the FDA on this study that may provide us with a better understanding of the impact of product regulation on tobacco prevention and cessation," said NIH Director Francis Collins.While smoking rates have dropped significantly since their peak in the 1960s, nearly 70 million Americans ages 12 and older were current users of tobacco products in 2010. As a result, death and disease caused by tobacco use is still a tremendous public health burden. Tobacco use is the leading preventable cause of disease, disability, and death in the United States. Cigarette smoking results in more than 443,000 premature deaths in the United States each year -- more than alcohol, illegal drug use, homicide, suicide, car accidents, and AIDS combined.

来源：资阳报